Fuse Vectors has raised $5.2 million of funding as it moves closer to commercialising its innovative new approach to ...
The funding will accelerate the development of Fuse's technology platform and pipeline of novel gene therapies. With its breakthrough approach, Fuse Vectors aims to be the universal solution for AAV ...
Gene therapy represents a paradigm shift in modern medicine, offering unprecedented opportunities to combat diseases at their ...
AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...
In some species, males only temporarily attach to females and then part ways. In others, such as C. holboelli, males permanently “fuse” with females, or females absorb multiple males—in some cases up ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.